Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia

Calcified Tissue International

Volumn 94, Issue 4, 2014, Pages 384-395

  Thomsen, Malissa Dawn ^a   Rejnmark, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bisphosphonate; Fibrous dysplasia; Focal bone lesion; McCune Albright syndrome; Osteoclast

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PHOSPHATE;

ADOLESCENT; ADULT; AGED; ALBRIGHT SYNDROME; ARTICLE; BIOCHEMISTRY; BONE PAIN; CAFE AU LAIT SPOT; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CRANIAL NERVE; CRANIAL NEUROPATHY; DISEASE COURSE; DISEASE SEVERITY; FACIAL BONE; FEMALE; FIBROUS DYSPLASIA; HUMAN; HYPOPHOSPHATEMIA; INFANT; MALE; MIDDLE AGED; MISSENSE MUTATION; MONO OSTOTIC FIBROUS DYSPLASIA; NEWBORN; ORTHOPEDIC SURGERY; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIODIAGNOSIS; RADIOLOGICAL OBSERVATION; SCHOOL CHILD; SYSTEMATIC REVIEW (TOPIC); YOUNG ADULT; BIOPSY; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DENMARK; FIBROBLAST; FIBROUS DYSPLASIA, POLYOSTOTIC; OSTEOBLAST; OSTEOLYSIS; RADIOGRAPHY; REGISTER;

ADOLESCENT; ADULT; AGED; BIOPSY; BONE RESORPTION; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DENMARK; DIPHOSPHONATES; FEMALE; FIBROBLASTS; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; INFANT; MALE; MIDDLE AGED; OSTEOBLASTS; REGISTRIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896491131     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-013-9829-0     Document Type: Article

References (40)

1. Chapurlat RD, Orcel P (2008) Fibrous dysplasia of bone and McCune-Albright syndrome. Best Pract Res Clin Rheumatol 22:55-69 (Pubitemid 351336924)
2. Feller L, Wood N, Khammissa R, Lemmer J, Raubenheimer E (2009) The nature of fibrous dysplasia. Head Face Med 5:22
3. Riminucci M, Kuznetsov SA, Cherman N, Corsi A, Bianco P, Robey PG (2003) Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone 33:434-442 (Pubitemid 37103260)
4. Kransdorf MJ, Moser RP, Gilkey FW (1990) Fibrous dysplasia. Radiographics 10:519-537
5. Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, Grill F, Lala R, Massobrio M, Pinggera O, Riminucci M, Snela S, Zambakidis C, Bianco P (2003) Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B 12:155-177 (Pubitemid 36578652)
6. Chapurlat RD, Hugueny P, Delmas PD, Meunier PJ (2004) Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone 35:235-242 (Pubitemid 38789170)
7. Chapurlat RD, Gensburger D, Jimenez-Andrade JM, Ghilardi JR, Kelly M, Mantyh P (2012) Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis 7(Suppl 1):S3
8. Mancini F, Corsi A, De Maio F, Riminucci M, Ippolito E (2009) Scoliosis and spine involvement in fibrous dysplasia of bone. Eur Spine J 18:196-202
9. Bhattacharyya N, Wiench M, Dumitrescu C, Connolly BM, Bugge TH, Patel HV, Gafni RI, Cherman N, Cho M, Hager GL, Collins MT (2012) Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res 27:1132-1141
10. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG (2001) Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16:806-813 (Pubitemid 32332290)
11. Yamamoto T, Imanishi Y, Kinoshita E, Nakagomi Y, Shimizu N, Miyauchi A, Satomura K, Koshiyama H, Inaba M, Nishizawa Y, Jüppner H, Ozono K (2005) The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome. J Bone Miner Metab 23:231-237 (Pubitemid 40603206)
12. DiCaprio MR, Enneking WF (2005) Fibrous dysplasia pathophysiology, evaluation, and treatment. J Bone Joint Surg 87:1848-1864 (Pubitemid 41061209)
13. Chattopadhyay A, Mohanty SK, Khandelwal N, Mathur SK, Dash RJ (2003) Hypophosphatemic rickets and osteomalacia in polyostotic fibrous dysplasia. J Pediatr Endocrinol Metab 16:893-896 (Pubitemid 37259177)
14. Woitge HW, Seibel MJ, Ziegler R (1996) Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases. Clin Chem 42:1796-1804 (Pubitemid 26371351)
15. Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotopedilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51:1683-1690 (Pubitemid 41233104)
16. Boyce AM, Glover M, Kelly MH, Brillante BA, Butman JA, Fitzgibbon EJ, Brewer CC, Zalewski CK, Cutler Peck CM, Kim HJ, Collins MT (2013) Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess. J Clin Endocrinol Metab 98:E126-E134
17. Bhadada SK, Bhansali A, Das S, Singh R, Sen R, Agarwal A, Mittal BR, Nahar U, Dutta P, Khandelwal N (2011) Fibrous dysplasia and McCune-Albright syndrome: an experience from a tertiary care centre in north India. Indian J Med Res 133:504-509
18. Fries JW (1957) The roentgen features of fibrous dysplasia of the skull and facial bones: a critical analysis of thirty-nine pathologically proved cases. Am J Roentgenol Radium Ther Nucl Med 77:71-88
19. Kruse A, Pieles U, Riener MO, Zunker C, Bredell MG, Gätz KW (2009) Craniomaxillofacial fibrous dysplasia: a 10-year database 1996-2006. Br J Oral Maxillofac Surg 47:302-305
20. Cai M, Ma L, Xu G, Gruen P, Li J, Yang M, Pan L, Guan H, Chen G, Gong J, Hu J, Qin S (2012) Clinical and radiological observation in a surgical series of 36 cases of fibrous dysplasia of the skull. Clin Neurol Neurosurg 114:254-259
21. Edgerton MT, Persing JA, Jane JA (1985) The surgical treatment of fibrous dysplasia, with emphasis on recent contributions from cranio-maxillo-facial surgery. Ann Surg 202:459-479 (Pubitemid 16248057)
22. Collins MT, Kushner H, Reynolds JC, Chebli C, Kelly MH, Gupta A, Brillante B, Leet AI, Riminucci M, Robey PG, Bianco P, Wientroub S, Chen CC (2005) An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Miner Res 20:219-226
23. Kelly MH, Brillante B, Collins MT (2008) Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int 19:57-63 (Pubitemid 350198055)
24. Parisi MS, Oliveri B, Mautalen CA (2003) Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia. Bone 33:582-588 (Pubitemid 37222384)
25. Lane JM, Khan SN, O'Connor WJ, Nydick M, Hommen JP, Schneider R, Tomin E, Brand J, Curtin J (2001) Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res 382:6-12 (Pubitemid 32047423)
26. Isaia GC, Lala R, Defilippi C, Matarazzo P, Andreo M, Roggia C, Priolo G, Sanctis C (2002) Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia. Calcif Tissue Int 71:121-128 (Pubitemid 36935476)
27. Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C (2000) Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 89:188-193 (Pubitemid 30339591)
28. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 88:4569-4575 (Pubitemid 37357495)
29. Chan B, Zacharin M (2006) Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood. J Pediatr Endocrinol Metab 19:75-80 (Pubitemid 43257423)
30. Liens D, Delmas PD, Meunier PJ (1994) Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343:953-954 (Pubitemid 24117233)
31. Parisi MS, Oliveri B (2009) Long-term pamidronate treatment of polyostotic fibrous dysplasia of bone: a case series in young adults. Curr Ther Res 70:161-172
32. Chao K, Katznelson L (2008) Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull. J Neurosurg 109:889-892
33. Mäkitie A, Törnwall J, Mäkitie O (2008) Bisphosphonate treatment in craniofacial fibrous dysplasia-a case report and review of the literature. Clin Rheumatol 27:809-812
34. Machida K, Makita K, Nishikawa J, Ohtake T, Iio M (1986) Scintigraphic manifestation of fibrous dysplasia. Clin Nucl Med 11:426-429 (Pubitemid 16020452)
35. Collins MT, Riminucci M, Bianco P, ASBMR (2008) Fibrous dysplasia. In primer on the metabolic bone diseases and disorders of mineral metabolism. Wiley, Hoboken, pp 423-427
36. Kuznetsov SA, Cherman N, Riminucci M, Collins MT, Robey PG, Bianco P (2008) Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone. J Bone Miner Res 23:1731-1740
37. Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, Farley FA, Molinolo AA, Bhattacharyya N, Collins MT (2012) Denosumab treatment for fibrous dysplasia. J Bone Miner Res 27:1462-1470
38. Kobayashi K, Imanishi Y, Koshiyama H, Miyauchi A, Wakasa K, Kawata T, Goto H, Ohashi H, Koyano HM, Mochizuki R, Miki T, Inaba M, Nishizawa Y (2006) Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci 78:2295-2301
39. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron RP (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112: 683-692 (Pubitemid 38057709)
40. Liamis G, Milionis HJ, Elisaf M (2010) Medication-induced hypophosphatemia: a review. QJM 103:449-459